A large increase in the use of kidneys from donation after circulatory death (DCD) donors prompted us to examine the impact of donor type on the incidence of ureteric complications (UCs; ureteric stenosis, urinary leak) after kidney transplantation. We studied 1072 consecutive kidney transplants (DCD n=494, live donor [LD] n=273, donation after brain death [DBD] n=305) performed during 2008-2014. Overall, there was a low incidence of UCs after kidney transplantation (3.5%). Despite a trend toward higher incidence of UCs in DCD (n=22, 4.5%) compared to LD (n=10, 3.7%) and DBD (n=5, 1.6%) kidney transplants, donor type was not a significant risk factor for UCs in multivariate analysis (DCD vs DBD HR: 2.33, 95% CI: 0.77-7.03, P=.13). There was no association between the incidence of UCs and donor, recipient, or transplant-related characteristics.
| INTRODUCTION
Ureteric complications (UC) after kidney transplantation are relatively uncommon but represent a significant cause of early and late morbidity. UCs comprise urinary leaks and stenosis, and their incidence in recently reported series ranges between 2.7% and 9.2%. [1] [2] [3] [4] The majority of UCs occur during the first year after transplantation; risk factors for early complications may include increased donor age, delayed graft function, and multiple renal arteries, 5 whereas later complications may be associated with acute rejection, BK virus nephropathy, or recurrent urinary infections. 6, 7 The stented extravesical anastomosis has now become the standard technique for ureteric implantation as it is associated with a relatively low complication rate. [8] [9] [10] When performing the ureteric implantation, preservation of the ureteric blood supply and avoidance of an unnecessarily long ureter are both thought to be important factors in minimizing UCs. 1 Increased demand for kidney transplantation has prompted an expansion of the deceased donor pool by greater use of "marginal" donor kidneys, including those from elderly donors and those with significant cardiovascular morbidity. There has also been a large increase in the use of kidneys from donation after circulatory death (DCD) donors.
It is widely thought that ischemic damage of the donor ureter due to compromised arterial blood supply may be a contributory factor to (DBD) donors, and DCD donors. 7 Since then, DCD transplant activity at our center has increased substantially, and we now perform twice as many DCD as DBD kidney transplants and routinely use DCD kidneys from elderly donors (>60 years old). 11 We therefore thought it would be timely to re-examine the impact of this change in clinical practice on the incidence and nature of UCs after kidney transplantation. 12 who incurred irrecoverable brain injury, but did not meet the criteria for diagnosis of brain stem death. Kidney procurement was performed as previously described, 13 and donation was pursued for a minimum of 4 hours after withdrawal of life-supporting treatment. Data were retrieved from a prospective, cross-audited, computerized database and by detailed case note review. Operating theater logs were also examined (in addition to the database search and case note review) to ensure identification of all recipients with UCs. The study was approved by the local institutional review board as a service evaluation.
| METHODS

| Study population
| Clinical information and variable definitions
Live donor kidneys were retrieved laparoscopically. Kidney transplants were routinely placed extraperitoneally in the left or right iliac fossa, and ureteroneocystostomy was performed using interrupted absorbable sutures (5/0 polydioxanone) over a double JJ (pigtail) ureteric stent. Ureteric stents were removed cystoscopically after approximately 6 weeks or earlier if indicated clinically by the presence of a urinary tract infection (UTI). Immunosuppression was administered according to standard protocols, as described previously. 7 Screening for BK viremia by polymerase chain reaction was performed routinely during the study period. Where surgical intervention was deemed necessary, it comprised re-implantation of the donor ureter onto the bladder or creation of a donor ureter to native ureter ureteroureterostomy or creation of a donor pelvis to native ureter pyeloureterostomy. All ureteric reconstructions were performed over a double pigtail ureteric stent, which was removed after approximately 6 weeks.
Extended criteria donors (ECD) were defined as those ≥60 years or those aged 50-59 years with two of the following three features:
hypertension; terminal serum creatinine >115 mmol/L; or death from cerebrovascular accident. 14 Delayed graft function was defined as the provision of dialysis in the first week after transplantation, and primary nonfunction was defined as a graft that never achieved sufficient function to allow discontinuation of dialysis, excluding acute vascular thrombosis. 15 UTIs were defined as urine samples from which bacteria were identified at microscopy and after culture. Recipient sensitization was defined as HLA-specific antibody reactivity (calculated reaction fre-
) against a panel of 10 000 consecutive UK organ donors. 
| RESULTS
During the 75-months study period, a total of 1072 kidney transplants (DCD n=494, LD n=273, DBD n=305) were performed at the Cambridge Transplant Centre. Of these, nine (0.8%) patients developed a urinary leak at a median (SD) of 28 (10) 16 cases (57.2%) involved the vesicoureteric junction or distal ureter, three cases (10.7%) the mid-ureter, and three cases (10.7%) the proximal ureter, and two cases (7.1%) had a long stricture (involving over half of the ureteric length). In four cases (14.3%), the involved ureteric segment was not specified. Twenty-six of the 28 cases of ureteric stenosis were treated by surgical reconstruction. One patient was treated for acute rejection following which their graft function improved and no further intervention was deemed necessary, and a further patient was treated with antegrade ureteric stent insertion. Only one patient presented with a recurrence of ureteric stenosis (overall recurrence rate was 2.7%) following ureteric reconstruction and was treated by creation of a donor pelvis to native ureter pyeloureterostomy.
The principal aim of this study was to determine whether there was any association between kidney donor type and incidence of UCs.
As shown in Table 2 , the incidence of UCs was numerically higher in recipient of DCD kidneys (4.5%) than for those who received LD kidneys (3.7%) and DBD kidneys (1.6%). In univariate analysis ( Figure 1 and When analyzing the incidence of urinary tract infections, a nested case-control study was constructed in which the comparison group consisted of one kidney transplant recipient immediately before and one kidney transplant recipient immediately after every case of UC (n=74). h For patients with UCs, BK viremia before the diagnosis of a UC was considered. BK viremia status was not available for 105 patients (two patients in the "UCs" group and 103 patients in the "No UCs" group). We next performed multivariable Cox proportional hazards regression analysis to determine risk factors for the development of UCs.
As shown in Table 3 , DCD kidney transplantation was not associated with a significant increase in the risk of UCs; this was also the case when the analysis was repeated, excluding cases of urinary leak (DCD vs DBD HR: 2.33, 95% CI: 0.77-7.03, P=.13). There was a trend toward increased risk of UCs in male kidney transplant recipients but that did not reach statistical significance in multivariable analysis (HR: 
| DISCUSSION
This large single-center retrospective cohort analysis showed that UCs remain an uncommon complication (3.5% overall) following renal transplantation. This is broadly similar to that observed in our previous analysis of an earlier transplant cohort where the overall rate of UCs was 2.7%. 7 Although UCs are uncommon, they give rise to significant morbidity and the vast majority of UCs in the present series required surgical intervention. No grafts were lost as a direct result of UCs. It was notable that the incidence of UCs was highest in recipients of DCD kidneys and lowest in recipients of DBD kidneys, although this difference was no longer statistically significant on multivariate analysis. Again, this is consistent with our earlier findings where the incidence of UCs was similar in recipients of DCD and DBD kidneys.
Urinary leaks were relatively rare (0.8%) in the present series, and this is likely attributable to the routine use of ureteric stents. 10 Urinary leaks typically occurred in the early postoperative period, and in four of the nine patients, the ureteric leak resolved with conservative management alone. Ureteric stenosis was three times more common than urinary leakage in this study and most commonly occurred in the first few months after kidney transplantation and often in the days following cystoscopic removal of the ureteric stent. The etiology of ureteric stenosis is not known, and it has been suggested that factors such as poor ureteric blood supply, UTI, and BK virus infection may all contribute. No obvious associations between these factors and the presence of ureteric stenosis were evident in our analysis. Our study showed a trend toward a increased risk of UCs in male kidney transplant recipients; a pathophysiological basis in support of this observation has not been described, but it is tempting to speculate that the presence of prostatic hypertrophy might be a contributing factor. In the present series, as in our earlier series, 7 the majority of UCs were treated by surgical intervention. Surgery was successful in all but one patient who required an additional surgical procedure to be performed. Others have reported on the effective treatment of ureteric stenosis by endourological approaches, most notably ureteric dilatation, although these approaches are associated with lower success rates and more complications than open surgical intervention. 17 It was notable that no recipient deaths or graft failures occurred in the present series as a direct result of UCs.
Kidneys from DCD donors are increasingly used for transplantation. It is notable that, in our previous analysis of an earlier transplant cohort, 7 22% of kidneys were from DCD donors, whereas in the present study, DCD kidneys accounted for 46% of the entire cohort.
While kidneys from such donors inevitably incur a period of significant ischemia-reperfusion injury, as evidenced by a higher rate of delayed graft function, they have comparable graft survival to that seen in recipients of kidneys from DBD donors. 18, 19 Moreover, as highlighted in the present study, kidneys from DCD donors have a numerically higher incidence of UCs compared to DBD kidneys, but the incidence of UCs is <5% and is not statistically significant when other variables are taken into account. Notably, we found no association between the warm ischemia time integral to DCD donation and risk of UCs, although the warm ischemia time was relatively short in this cohort. It is important to acknowledge some limitations of the present study. This was a single-center, retrospective, observational, cohort study that investigated a relatively uncommon complication after kidney transplantation raising the possibility of a type II error. A randomized controlled trial would have been required to definitively address the association between donor type and risk of UCs, but this would have to include a large sample size to ensure adequate power and is, therefore, likely to be impractical. Despite the limitations of the study design, the present study is one of the largest of its kind to date, in which DCD transplants comprised almost half of the entire cohort. It is also important to acknowledge that, despite performing a nested case-control study to investigate the potential association of UTI and the risk of developing UCs, inclusion of the entire patient cohort might have been more informative.
In conclusion, the present series shows that, despite a significant increase in the number of kidney transplants from DCD donors, the incidence of UCs remains low. No obvious predisposing factors to UCs were identified in our analysis. When UCs do occur, they can be treated successfully with surgical reconstruction with no adverse effect on graft or patient survival. 
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